ICER Update 01.27.22
Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. ICER has published its latest report on Unsupported Price Increases (UPI) of prescription
January 27, 2022
No Comments
Q2 2020 Excelsior Newsletter
The Rebate Bubble by Jonalan Smith, PharmD, FASCP, Senior Vice President Everyone knows the recent ‘bubbles’ that have impacted the economy in major way: The
July 13, 2020
No Comments
Q1 2020 Excelsior Newsletter
The Impact Of Humira Citrate-Free by Bob Kordella, R.Ph., MBA Humira is typically in the top five drugs by spend for most plan sponsors. In
May 12, 2020
No Comments
ICER Update 02.27.20
Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update.Here is this week’s ICER recap: ICER released a Draft Evidence Report for
May 12, 2020
No Comments
ICER Update 03.23.20
NOTE: Since today’s update was written, ICER has announced either the indefinite postponement (Sickle Cell Disease, Cystic Fibrosis) or 2 to 3 month delay (NASH,
April 23, 2020
No Comments
ICER Update 01.29.20
Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released a draft evidence report
January 29, 2020
No Comments
Q4 2019 Excelsior Newsletter
HIV PrEP Therapies by Darian Hurst, Vice President In June 2019, the United States Preventive Services Task Force (USPSTF) published a final recommendation that clinicians
December 27, 2019
No Comments
ICER Update 10.21.19
Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released an updated Draft Evidence
October 21, 2019
No Comments
ICER Update 10.07.19
Hello, everyone, and welcome to a very full edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER posted a Draft Scoping
October 7, 2019
No Comments
ICER Update 09.30.19
Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: 1. ICER released a Draft Evidence Report
September 30, 2019
No Comments